#$%^&*AU2016202224A120160505.pdf#####TARGETING MICRORNAS FOR METABOLIC DISORDERS Abstract: Provided herein are methods and compositions for the treatment of metabolic disorders. Also provided herein are methods and compositions for the reduction of blood glucose level, the reduction of gluceoneogenesis, the improvement of insulin resistance and the reduction of plasma cholesterol level. In certain embodiments, the methods comprise inhibiting the activity of miR-1 03. In certain embodiments, the methods comprise inhibiting the activity of miR-107. In certain embodiments, the activity of both miR -103 and miR -107 is inhibited. In certain embodiments, such methods comprise administering a compound comprising an oligonucleotide targeted to a microRNA. (1114R240 11-MA；H
